You must have the Adobe Flash Player installed to view this player.
Conformetrix brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular structures with high accuracy, Conformetrix is focused on optimising the design and development of medicines and helping the pharmaceutical sector to generate better, safer products.
Conformetrix is able to determine the bioactive 3D structures of a variety of biologically important molecules, including drugs, naturally occurring ligands and enzyme co-factors, and does this independently of traditional methods such as computational modelling and X-ray crystallography.
Conformetrix is using its technology to develop a pipeline of proprietary drugs against therapeutically important targets and is partnering with the pharmaceutical industry in the implementation of its technology across the drug discovery process.
